SCOPUS 정보 검색 플랫폼

Drug Discovery Today

Volumn 21, Issue 3, 2016, Pages 379-384

The changing model of big pharma: Impact of key trends

(2) Gautam, Ajay a Pan, Xiaogang a

a ASTRAZENECA (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG INDUSTRY; DRUG MANUFACTURE; HEALTH CARE ACCESS; HUMAN; MARKET; PATENT; PRIMARY MEDICAL CARE; PRODUCTIVITY; REIMBURSEMENT; REVIEW; SCIENTIST; COST; RESEARCH; TRENDS;

BIOLOGICAL PRODUCT;

BIOLOGICAL PRODUCTS; COSTS AND COST ANALYSIS; DRUG INDUSTRY; RESEARCH;

EID: 84961927124 PISSN: 13596446 EISSN: 18785832 Source Type: Journal
DOI: 10.1016/j.drudis.2015.10.002 Document Type: Short Survey

Times cited : (100)

References (12)

1
- 77649234756
- How to improve R&D productivity: The pharmaceutical industry's grand challenge
- S.M. Paul, and et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge Nat. Rev. Drug Discov. 9 2010 203 214
- (2010) Nat. Rev. Drug Discov. , vol.9 , pp. 203-214
- Paul, S.M.¹

2
- 84866739808
- Drug discovery in pharmaceutical industry: Productivity challenges and trends
- I. Khanna Drug discovery in pharmaceutical industry: productivity challenges and trends Drug Discov. Today 17 2012 1088 1102
- (2012) Drug Discov. Today , vol.17 , pp. 1088-1102
- Khanna, I.¹

3
- 78651297594
- The problems with today's pharmaceutical business - An outsider's view
- M. Kessel The problems with today's pharmaceutical business - an outsider's view Nat. Biotechnol. 29 2011 27 33
- (2011) Nat. Biotechnol. , vol.29 , pp. 27-33
- Kessel, M.¹

4
- 84961929134
- Understanding new commercial models
- IMS Health Report (2009) Understanding new commercial models. Available at: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/StaticFile/Understanding-New-Commercial-Models.pdf
- (2009) IMS Health Report

5
- 79952432779
- Strategies for emerging markets: Seven keys to the kingdom
- W. Looney Strategies for emerging markets: seven keys to the kingdom Pharma. Executive 30 2010 8
- (2010) Pharma. Executive , vol.30 , pp. 8
- Looney, W.¹

6
- 84906822340
- A framework for biomedical innovation in emerging markets
- A. Gautam, and S. Yang A framework for biomedical innovation in emerging markets Nat. Rev. Drug Discov. 13 2014 646 647
- (2014) Nat. Rev. Drug Discov. , vol.13 , pp. 646-647
- Gautam, A.¹ Yang, S.²

7
- 84925284032
- Evolution of Chinese bioclusters as a framework for investment policies in emerging markets
- A. Gautam Evolution of Chinese bioclusters as a framework for investment policies in emerging markets Nat. Rev. Drug Discov. 14 2015 8
- (2015) Nat. Rev. Drug Discov. , vol.14 , pp. 8
- Gautam, A.¹

8
- 84930601879
- IMS Health (2014) Global outlook for medicines through 2018. Available at: http://www.imshealth.com/portal/site/imshealth/menuitem.762a961826aad98f53c753c71ad8c22a/?vgnextoid=6011f106fe3c9410VgnVCM10000076192ca2RCRD
- (2014) Global Outlook for Medicines Through 2018

9
- 84942292465
- Inflammation and cancer: Advances and new agents
- S.M. Crusz, and F.R. Balkwill Inflammation and cancer: advances and new agents Nat. Rev. Clin. Oncol. 12 2015 584 596
- (2015) Nat. Rev. Clin. Oncol. , vol.12 , pp. 584-596
- Crusz, S.M.¹ Balkwill, F.R.²

10
- 84900314611
- CRISPR-Cas systems for editing, regulating and targeting genomes
- J.D. Sander, and J.K. Joung CRISPR-Cas systems for editing, regulating and targeting genomes Nat. Biotechnol. 32 2014 347 355
- (2014) Nat. Biotechnol. , vol.32 , pp. 347-355
- Sander, J.D.¹ Joung, J.K.²

11
- 84921794613
- MRNA-based therapeutics - Developing a new class of drugs
- U. Sahin, and et al. mRNA-based therapeutics - developing a new class of drugs Nat. Rev. Drug Discov. 13 2014 759 780
- (2014) Nat. Rev. Drug Discov. , vol.13 , pp. 759-780
- Sahin, U.¹

12
- 84961969575
- The world's biggest public companies
- Forbes Global 2000 Companies List (2015) The world's biggest public companies. Available at: http://www.forbes.com/global2000/list/
- (2015) Forbes Global 2000 Companies List

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.